Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: Italy Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20021
20051
20064
20072
20091
20112
20143
20151
20161
20171
20181
20191
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting4
Terminated4
Active, not recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Revolution Medicines, Inc.3
Celgene2
Eli Lilly and Company2
Hoffmann-La Roche2
Incyte Corporation2
Sanofi2
Amgen1
Arcus Biosciences, Inc.1
AstraZeneca1
Azienda Ospedaliero, Universitaria Pisana1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms31
Neoplasms4
Adenocarcinoma3
Endocrine Gland Neoplasms3
Neoplasm Metastasis3
Digestive System Diseases2
Digestive System Neoplasms2
Endocrine System Diseases2
Neoplasms by Site2
Pancreatic Diseases2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.